- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
BIO-key International Enhances Secure Biometric Authentication with HealthIDx Partnership
BIO-key International, Inc. (OTCQB: BKYI) has improved its offering of secure biometric authentication by adding robust identity proofing services and optional hosted authentication services in partnership with HealthIDx, a Credential Services Provider (CSP).
BIO-key International, Inc. (OTCQB: BKYI) has improved its offering of secure biometric authentication by adding robust identity proofing services and optional hosted authentication services in partnership with HealthIDx, a Credential Services Provider (CSP).
According to the press release:
This enhancement significantly expands the markets for BIO-key’s authentication products, and will allow many more health systems to avail themselves of BIO-key’s superior user experience for ePrescribing authentication. While the immediate beneficiaries are in healthcare, non-healthcare market customers can also leverage BIO-key’s identity proofing service to ensure positive identity of enrolled individuals into their BIO-key applications.
“We’re excited to be partnering with BIO-key in this important effort to increase the security, ease of use, and cost effectiveness of ePrescribing solutions,” said Scott Lowry, CEO of HealthIDx.
BIO-key has a strong track record providing “biometric plus” two-factor authentication solutions with its ID Director family of products, providing seamless integration into ePrescribing platforms from EPIC and Allscripts, with more integrations in development. Healthcare customers choose BIO-key because of the day-to-day operational impact of its outstanding National Institute of Standards and Technology (NIST) accuracy tests, scalable 1-to-many search, and device interoperability. NIST’s reports (https://www.nist.gov/itl/iad/ig/pftii_results.cfm) demonstrate that BIO-key’s accuracy results are orders of magnitude better than competitive offerings being sold at higher prices. BIO-key’s superior accuracy directly impacts prescribers every day with an improved biometric experience, and allows the highest standards of security to be met without compromise.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.